Funder: The Swedish Esophageal Cancer Study was funded by grants (R01 CA57947-03) from the National Cancer Institute he California Tobacco Related Research Program (3RT-0122; and; 10RT-0251) Marit Peterson Fund for Melanoma Research. CIDR is supported by contract HHSN268200782096CAbstract: Gastroesophageal reflux disease (GERD) is caused by gastric acid entering the esophagus. GERD has high prevalence and is the major risk factor for Barrett’s esophagus (BE) and esophageal adenocarcinoma (EA). We conduct a large GERD GWAS meta-analysis (80,265 cases, 305,011 controls), identifying 25 independent genome-wide significant loci for GERD. Several of the implicated genes are existing or putative drug targets. Loci discovery is greatest with a bro...
Important risk factors for esophageal adenocarcinoma (EA) and its precursor, Barrett’s esophagus (BE...
Esophageal adenocarcinoma (EA) is an increasingly common cancer with poor survival. Barrett’s esopha...
Background & Aims: Genome-wide association studies (GWAS) have identified more than 20 susceptibilit...
Gastroesophageal reflux disease (GERD) is caused by gastric acid entering the esophagus. GERD has hi...
Gastroesophageal reflux disease (GERD) is caused by gastric acid entering the esophagus. GERD has hi...
Objective: Gastro-oesophageal reflux disease (GERD) has heterogeneous aetiology primarily attributab...
Objective: Gastro-oesophageal reflux disease (GERD) has heterogeneous aetiology primarily attributab...
OBJECTIVE: Gastro-oesophageal reflux disease (GERD) has heterogeneous aetiology primarily attributab...
Esophageal adenocarcinoma (EA) is a rapidly fatal cancer with rising incidence in the developed worl...
BACKGROUND & AIMS: Genome-wide association studies (GWAS) have identified more than 20 susceptibilit...
Background Esophageal adenocarcinoma (EA) is an increasingly common cancer with poor survival. Barre...
SUMMARY Background: Esophageal adenocarcinoma (EA) represents one of the fastest rising oncological...
Background Esophageal adenocarcinoma (EA) is one of the fastest rising cancers in western countries....
Objective Oesophageal cancer (EC) is the sixth leading cause of cancer-related deaths. Oesophageal a...
Aims: The aims of this study were to confirm, in a prospective study, the link between gastroesophag...
Important risk factors for esophageal adenocarcinoma (EA) and its precursor, Barrett’s esophagus (BE...
Esophageal adenocarcinoma (EA) is an increasingly common cancer with poor survival. Barrett’s esopha...
Background & Aims: Genome-wide association studies (GWAS) have identified more than 20 susceptibilit...
Gastroesophageal reflux disease (GERD) is caused by gastric acid entering the esophagus. GERD has hi...
Gastroesophageal reflux disease (GERD) is caused by gastric acid entering the esophagus. GERD has hi...
Objective: Gastro-oesophageal reflux disease (GERD) has heterogeneous aetiology primarily attributab...
Objective: Gastro-oesophageal reflux disease (GERD) has heterogeneous aetiology primarily attributab...
OBJECTIVE: Gastro-oesophageal reflux disease (GERD) has heterogeneous aetiology primarily attributab...
Esophageal adenocarcinoma (EA) is a rapidly fatal cancer with rising incidence in the developed worl...
BACKGROUND & AIMS: Genome-wide association studies (GWAS) have identified more than 20 susceptibilit...
Background Esophageal adenocarcinoma (EA) is an increasingly common cancer with poor survival. Barre...
SUMMARY Background: Esophageal adenocarcinoma (EA) represents one of the fastest rising oncological...
Background Esophageal adenocarcinoma (EA) is one of the fastest rising cancers in western countries....
Objective Oesophageal cancer (EC) is the sixth leading cause of cancer-related deaths. Oesophageal a...
Aims: The aims of this study were to confirm, in a prospective study, the link between gastroesophag...
Important risk factors for esophageal adenocarcinoma (EA) and its precursor, Barrett’s esophagus (BE...
Esophageal adenocarcinoma (EA) is an increasingly common cancer with poor survival. Barrett’s esopha...
Background & Aims: Genome-wide association studies (GWAS) have identified more than 20 susceptibilit...